![](/img/cover-not-exists.png)
High-dose chemotherapy (HDC) with autologous progenitor cell support (APCS) for breast cancer patients with high risk stage II–III, and stage IV with no evidence of disease (NED)
Stemmer, S.M., Jones, R.B., Shpall, E.J., Bearman, S.I., Myers, S.E., Taffs, S., McDermitt, J.Volume:
29
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/0959-8049(93)90989-S
Date:
January, 1993
File:
PDF, 128 KB
english, 1993